Oxford university vaccine trial for corona virus
Initial results from the corona virus vaccine developed by Oxford University have arrived and it appears to be safe and enabling the immune system to fight the disease.
It was injected to 1,077 people to make antibodies and white blood cells to fight the corona virus.
The results of this study are very positive, but it is too early to say that it is enough to protect against this disease and it requires large-scale trials.
The UK has ordered 10 million doses of the drug.
The health reporters say the main purpose of the trials is to make sure they can be given safely to more people.
But we may also find out the reaction of the immune system to the 'jab', whether it produces antibodies or activates other parts of the immune system.
"What we don't know today is whether this vaccine 'works', whether it protects you from infection or at least reduces the symptoms."
This requires a large number of people to be included in the trials, even in countries where there are far more coronavirus victims than in the UK.
Working of vaccine
This vaccine is called ChAdOx1 nCoV-19, which is being developed so fast that there is no precedent for it.
The vaccine is being developed from a genetically modified virus that infects monkeys with the common cold.
The virus has been modified so that it does not infect humans and looks like a corona virus.
To do this, scientists have transmitted the genetic properties of coronavirus-like proteins in the body to the vaccine. This means that the vaccine will be similar to the corona virus and the human immune system will learn how to attack the corona virus.
Mashallah it's a good news
ReplyDeleteofcourse much awaited news
Deletewe all are waiting for it.
ReplyDeleteeveryone is waiting for it
Deletenice
ReplyDeletethanks
Delete